DNA origami puts a smart lid on solid-state nanopore sensors

The latest advance in solid-state nanopore sensors - devices that are made with standard tools of the semiconductor industry yet can offer...

Unique adaptations to a symbiotic lifestyle reveal novel targets for aphid insecticides

Aphids are pests that cause millions of pounds of damage to crops in the UK, but new research led by biologists at the University of York reveals potential new targets for aphid-specific insecticides.

Jenway’s new top-of-the-range 6850 spectrophotometer

The 6850 UV/visible spectrophotometer is Jenway’s first double-beam instrument with a variable spectral bandwidth – of 5nm down to...

Fleming Europe: Making Pharma Transparent

Stricter regulations and various requirements in pharma ensure that the industry is ever-evolving and moving forward. From improving the quality process, reducing costs and remarkable progress in R&D, now is the optimal time to look at the...

Antisense Pharma receives FDA Orphan Drug Designation for Trabedersen to treat Malignant Melanoma

The biopharmaceutical company Antisense Pharma GmbH announces that the US Food and Drug Administration (FDA) has granted Orphan Drug designation for its investigational oncology antisense compound trabedersen to treat malignant melanoma.

Cosmetics: pioneering the way towards animal free testing

SEURAT-1 is the first phase of a longer term research initiative aiming at Safety Evaluation Ultimately Replacing Animal Testing.

Queen's University scientist awarded top prize

A female scientist from the Queen's University Ionic Liquid Laboratories (QUILL) Research Centre has won a prestigious fellowship for her work on ionic liquids enabling biomedical applications.

CureBeta, a collaboration between Evotec and Harvard University enters strategic alliance with Janssen Pharmaceuticals

Evotec AG has announced that it has licensed to Janssen Pharmaceuticals, Inc. a portfolio of small molecules and biologics designed to trigger the regeneration of insulin-producing beta cells.

Discovery improves understanding of early onset inflammatory disease

Scientists at the University of East Anglia have discovered a ‘constant cloud’ of potent inflammatory molecules surrounding the cells responsible for diseases such as thickening of the arteries and rheumatoid arthritis.

Scientists to investigate 'magic-bullet' cancer therapy

Scientists at the University of Sheffield will investigate a new ‘magic-bullet’ cancer therapy that exploits tumour cells’ greed for fat, following an award from Yorkshire Cancer Research.

South African daffodils may be a future cure for depression

Scientists have discovered that plant compounds from a South African flower may in time be used to treat diseases originating in the brain...

Feasibility of high-yield production of PASylated Biopharmaceuticals

Wacker Biotech and XL-protein have successfully completed a feasibility study on the production of PASylated therapeutic proteins using WACKER’s ESETEC® E. coli secretion technology.

The environment and pharmaceuticals and personal care products: What are the big questions?

Researchers at the University of York headed a major international review aimed at enhancing efforts to better understand the impacts of chemicals used in pharmaceuticals or in personal care products, such as cosmetics, soaps, perfumes,...




To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited